ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

NCT07173751 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Pumitamig
DRUG: Nab-paclitaxel/Paclitaxel
DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Eribulin
DRUG: Matching placebo

Sponsor

BioNTech SE

Collaborators

[object Object]